Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Photodiagnosis and Photodynamic Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1572100025000146 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832575490865496064 |
|---|---|
| author | Kai Ching Peter Leung Sunny, Chi Lik Au |
| author_facet | Kai Ching Peter Leung Sunny, Chi Lik Au |
| author_sort | Kai Ching Peter Leung |
| collection | DOAJ |
| format | Article |
| id | doaj-art-f404205cc5f248f6a8092ccca17ddabe |
| institution | Kabale University |
| issn | 1572-1000 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Photodiagnosis and Photodynamic Therapy |
| spelling | doaj-art-f404205cc5f248f6a8092ccca17ddabe2025-02-01T04:11:50ZengElsevierPhotodiagnosis and Photodynamic Therapy1572-10002025-02-0151104484Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edemaKai Ching Peter Leung0Sunny, Chi Lik Au1Department of Ophthalmology, Tung Wah Eastern Hospital, Hong KongCorresponding author at: Lo Ka Chow Memorial Ophthalmic Centre, Tung Wah Eastern Hospital, 9/F, MO Office, 19 Eastern Hospital Road, Causeway Bay, Hong Kong.; Department of Ophthalmology, Tung Wah Eastern Hospital, Hong Konghttp://www.sciencedirect.com/science/article/pii/S1572100025000146Laser therapyIntravitreal injectionsVascular endothelial growth factor AMacular edemaDiabetic retinopathyRetina |
| spellingShingle | Kai Ching Peter Leung Sunny, Chi Lik Au Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema Photodiagnosis and Photodynamic Therapy Laser therapy Intravitreal injections Vascular endothelial growth factor A Macular edema Diabetic retinopathy Retina |
| title | Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema |
| title_full | Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema |
| title_fullStr | Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema |
| title_full_unstemmed | Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema |
| title_short | Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema |
| title_sort | dosing intervals in comparison of one year real world outcomes between red 670 nm subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment naive diabetic macular edema |
| topic | Laser therapy Intravitreal injections Vascular endothelial growth factor A Macular edema Diabetic retinopathy Retina |
| url | http://www.sciencedirect.com/science/article/pii/S1572100025000146 |
| work_keys_str_mv | AT kaichingpeterleung dosingintervalsincomparisonofoneyearrealworldoutcomesbetweenred670nmsubthresholdmicropulselasertreatmentandintravitrealafliberceptinjectionfortreatmentnaivediabeticmacularedema AT sunnychilikau dosingintervalsincomparisonofoneyearrealworldoutcomesbetweenred670nmsubthresholdmicropulselasertreatmentandintravitrealafliberceptinjectionfortreatmentnaivediabeticmacularedema |